References
- Stegelmeier BL, Edgar JA, Colegate SM, Gardner DR, Schoch TK, Coulombe RA, Molyneux RJ. Pyrrolizidine alkaloid plants, metabolism and toxicity. J Nat Toxins 1999; 8:95–116.
- Coppell JA, Brown SA, Perry DJ. Veno-occlusive disease: cytokines, genetics, and haemostasis. Blood Rev 2003; 17:63–70.
- Deleve LD. Dacarbazine toxicity in murine liver cells: a model of hepatic endothelial injury and glutathione defense. J Pharmacol Exp Ther 1994; 268:1261–1270.
- Eisenberg S. Hepatic sinusoidal obstruction syndrome in patients undergoing hematopoietic stem cell transplant. Oncol Nurs Forum 2008; 35:385–397.
- VT Ho, C Revta, Richardson PG. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies. Bone Marrow Transpl 2008; 41:229–237.
- Dai N, Yu YC, Ren TH, Wu JG, Jiang Y, Shen LG, Zhang J. Gynura root induces hepatic veno-occlusive disease: a case report and review of the literature. World J Gastroenterol 2007; 13:1628–1631.
- Dai HF, Gao Y, Yang M, Yu CH, Gu ZY, Chen WX. Hepatic veno-occlusive disease induced by Gymura segetum: report of two cases. Hepatobiliary Pancreat Dis Int 2006; 5:406–408.
- Coppell JA, Richardson PG, Soiffer R, Martin PL, Kernan NA, Chen A, et al.Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant 2010; 16:157–168.
- Zuckerman M, V Steenkamp, Stewart MJ. Hepatic veno-occlusive disease as a result of a traditional remedy: confirmation of toxic pyrrolizidine alkaloids as the cause, using an in vitro technique. J Clin Pathol 2002; 55:676–679.
- World Health Organization 1988. Pyrrolizidine alkaloids, environmental health criteria noet al 80, Geneva, Switzerland: World Health Organization. http://www.inchem.org/documents/ehc/ehc/ehc080. htm . Accessed 16 October 2010.